A Study of Tocilizumab in Comparison to Etanercept in Participants With Rheumatoid Arthritis and Cardiovascular Disease Risk Factors
Clinical trial NCT01331837 · COMPLETED
Trial details
- NCT number
- NCT01331837
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-02
- Primary completion
- 2016-03-25
- Enrollment
- 3080
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.